Literature DB >> 10964501

Mass cultured human fibroblasts overexpressing hTERT encounter a growth crisis following an extended period of proliferation.

K L MacKenzie1, S Franco, C May, M Sadelain, M A Moore.   

Abstract

During the process of immortalization, at least two mortality checkpoints, M1 and M2, must be bypassed. Cells that have bypassed M1 (senescence) have an extended life span, but are not necessarily immortal. Recent studies have shown that ectopic expression of the catalytic subunit of telomerase (hTERT) enables normal human cells to bypass senescence (M1) and oncogene transformed cells to avert crisis (M2) and become immortal. However, it is unclear whether hTERT expression is sufficient for normal human fibroblasts to overcome both M1 and M2 and become immortal. We have investigated the role of telomerase in immortalization by maintaining mass cultures of hTERT-transduced primary human fetal lung fibroblasts (MRC-5 cells) for very long periods of time (more than 2 years). In the present studies, up to 70% of MRC-5 cells were transduced with retroviral vectors that express hTERT. hTERT-transduced cells exhibited high levels of telomerase activity, elongation of telomeres, and proliferation beyond senescence. However, after proliferating for more than 36 population doublings (PDLs) beyond senescence, the overall growth rate of hTERT-expressing cells declined. During theses periods of reduced growth, hTERT-transduced MRC-5 cells exhibited features typical of cells in crisis, including an increased rate of cell death and polyploidy. In some instances, very late passage cells acquired a senescence-like phenotype characterized by arrest in the G1 phase of the cell cycle and greatly reduced DNA synthesis. At the onset of crisis, hTERT-transduced cells expressed high levels of telomerase and had very long telomeres, ranging up to 30 kb. Not all cells succumbed to crisis and, consequently, some cultures have proliferated beyond 240 PDLs, while another culture appears to be permanently arrested at 160 PDLs. Late passage MRC-5 cells, including postcrisis cells, displayed no signs of malignant transformation. Our results are consistent with the model in which telomerase and telomere elongation greatly extends cellular life span without inducing malignant changes. However, these investigations also indicate that hTERT-expressing cells may undergo crisis following an extended life span and that immortality is not the universal outcome of hTERT expression in normal diploid fibroblasts. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10964501     DOI: 10.1006/excr.2000.4982

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  17 in total

Review 1.  Pro-senescence therapy for cancer treatment.

Authors:  Caterina Nardella; John G Clohessy; Andrea Alimonti; Pier Paolo Pandolfi
Journal:  Nat Rev Cancer       Date:  2011-06-24       Impact factor: 60.716

2.  Telomere and telomerase in the initial stage of immortalization of esophageal epithelial cell.

Authors:  Zhong-Ying Shen; Li-Yan Xu; En-Min Li; Wei-Jia Cai; Min-Hua Chen; Jian Shen; Yi Zeng
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

3.  HIV-1 induces telomerase activity in monocyte-derived macrophages, possibly safeguarding one of its reservoirs.

Authors:  Rita Reynoso; Matthias Wieser; Diego Ojeda; Maximilian Bönisch; Harald Kühnel; Federico Bolcic; Heribert Quendler; Johannes Grillari; Regina Grillari-Voglauer; Jorge Quarleri
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

4.  WNT16B is a new marker of cellular senescence that regulates p53 activity and the phosphoinositide 3-kinase/AKT pathway.

Authors:  Romuald Binet; Damien Ythier; Ana I Robles; Manuel Collado; Delphine Larrieu; Claire Fonti; Elisabeth Brambilla; Christian Brambilla; Manuel Serrano; Curtis C Harris; Rémy Pedeux
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

5.  Telomerase and telomere length in pulmonary fibrosis.

Authors:  Tianju Liu; Matthew Ullenbruch; Yoon Young Choi; Hongfeng Yu; Lin Ding; Antoni Xaubet; Javier Pereda; Carol A Feghali-Bostwick; Peter B Bitterman; Craig A Henke; Annie Pardo; Moises Selman; Sem H Phan
Journal:  Am J Respir Cell Mol Biol       Date:  2013-08       Impact factor: 6.914

6.  Telomerase-mediated lifespan extension of human bronchial cells does not affect hexavalent chromium-induced cytotoxicity or genotoxicity.

Authors:  Sandra S Wise; Lynne W Elmore; Shawn E Holt; Jennifer E Little; Peter G Antonucci; Bronwyn H Bryant; John Pierce Wise
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

7.  Malignant transformation in a defined genetic background: proteome changes displayed by 2D-PAGE.

Authors:  Stephanie M Pütz; Fotini Vogiatzi; Thorsten Stiewe; Albert Sickmann
Journal:  Mol Cancer       Date:  2010-09-22       Impact factor: 27.401

8.  Up-regulation of survivin during immortalization of human myofibroblasts is linked to repression of tumor suppressor p16(INK4a) protein and confers resistance to oxidative stress.

Authors:  Chin-Yi Kan; Carlotta Petti; Lauryn Bracken; Michelle Maritz; Ning Xu; Rosemary O'Brien; Chen Yang; Tao Liu; Jun Yuan; Richard B Lock; Karen L MacKenzie
Journal:  J Biol Chem       Date:  2013-02-28       Impact factor: 5.157

Review 9.  New prospects for targeting telomerase beyond the telomere.

Authors:  Greg M Arndt; Karen L MacKenzie
Journal:  Nat Rev Cancer       Date:  2016-06-24       Impact factor: 60.716

10.  Why Cockayne syndrome patients do not get cancer despite their DNA repair deficiency.

Authors:  Kate S Reid-Bayliss; Sarah T Arron; Lawrence A Loeb; Vladimir Bezrookove; James E Cleaver
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.